Document is current

Any future updates will be listed below

Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)

Crossref DOI link: https://doi.org/10.1186/s12883-016-0629-9

Published Online: 2016-07-19

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark